
|Articles|December 27, 2021
FDA approves HIV pre-exposure preventive injection
Author(s)Keith A. Reynolds
Apretude is approved for use in at-risk adults and adolescents to reduce the risk of sexually acquired HIV.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Cannabidiol and THC show synergistic anti-cancer effects in ovarian cancer cell models
2
Tiny Tim: Can you guess the diagnosis?
3
Violence against women and children reported a top global health risk
4
Joshua Hare, MD, FAAC, highlights stem cell therapy for female sexual dysfunction
5











